What is Connect Biopharma Holdings Ltd (CNTB) stock price today?

Connect Biopharma Holdings Ltd (CNTB) currently trades at $2.53 per share. The stock has a market capitalization of $142.43M and a P/E ratio of —x.

Is CNTB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Connect Biopharma Holdings Ltd has a Smart Value Score of 20/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Connect Biopharma Holdings Ltd's revenue and earnings?

Connect Biopharma Holdings Ltd has trailing twelve-month (TTM) revenue of $64000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.00.

CNTB

Connect Biopharma Holdings Ltd

NASDAQ: CNTB · HEALTHCARE · BIOTECHNOLOGY

$2.53

+5.42% today

Updated 2026-04-29

Market cap

$142.43M

P/E ratio

—

P/S ratio

2,225.53x

EPS (TTM)

$-1.00

Dividend yield

—

52W range

$1 – $4

Volume

0.3M

Market cap

$142.43M

P/E ratio

—

P/S ratio

2,225.53x

EPS (TTM)

$-1.00

Dividend yield

—

52W range

$1 – $4

Volume

0.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$7.90

+212.25%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-17.54M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$26.03M	$64000.00	$64000.00
Net income	$-118.09M	$-62.11M	$-15.63M	$-55.48M	$-15.11M
EPS	—	—	—	—	$-1.00
Free cash flow	$-103.55M	$-48.22M	$-24.36M	$-51.64M	$-17.54M
Profit margin	—	—	-60.03%	-86,687.50%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CNTB	$142.43M	20	3.7	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Connect Biopharma Holdings Ltd trades at $2.53. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $64000.00.

Frequently asked questions

What is Connect Biopharma Holdings Ltd's stock price?

Connect Biopharma Holdings Ltd (CNTB) trades at $2.53.

Is Connect Biopharma Holdings Ltd overvalued?

Smart Value Score 20/100 (Grade F, Strong Sell).

What is the price target of Connect Biopharma Holdings Ltd (CNTB)?

The analyst target price is $7.90, representing +212.3% upside from the current price of $2.53.

What is Connect Biopharma Holdings Ltd's revenue?

TTM revenue is $64000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio2,225.53x

ROE-82.70%

Beta-0.18

50D MA$2.77

200D MA$2.25

Shares out0.06B

Float0.01B

Short ratio—

Avg volume0.3M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CNTB vs LLY →CNTB vs JNJ →CNTB vs ABBV →Stock screener →